Scott Sherman
Scott Sherman, MD, MPH
NYU Langone Health - Professor of Population Health, Medicine and Psychiatry
NYU College of Global Public Health - Professor of Global Public Health
NYU Langone Health - Co-Chief, Section on Tobacco, Alcohol and Drug Use, Department of Population Health
MD, Medicine, New York University School of Medicine
MPH, Epidemiology & Biostatistics, Boston University School of Public Health
AB, Mathematics, Brown University
Research Interests
Smoking cessation, Alternative tobacco products, Substance abuse/dependence, Health services research, Implementation research
After receiving his MD from NYU School of Medicine, Scott Sherman completed a residency in Primary Care Internal Medicine at Bellevue Hospital and then a research fellowship in General Internal Medicine at Boston University. Dr. Sherman joined the faculty at University of California, Los Angeles in 1991 and was a staff physician for the Veterans Health Administration (VA). In 2005, he transferred back to New York City, where he is currently Professor of Population Health, Medicine and Psychiatry at NYU School of Medicine and Co-Chief of the Section of Tobacco, Alcohol and Drug Use. Dr. Sherman’s main area of interest is how to redesign health care systems to better help people quit smoking. He is particularly focused on Translational Studies, which examine the effectiveness of interventions in routine practice, as well as how to disseminate and implement them. Dr. Sherman is currently PI/MPI of seven major grants: 1) a mid-career mentoring award (K24 – NIH/NIDA), 2) A behavioral economic intervention to improve psychiatrist adherence to tobacco treatment guidelines (R34 – NIDA), 3) Integrating Financial Management and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants (Robin Hood Foundation) 4) Center for Alternative Tobacco Product Studies (New York State), 5) Text messaging to engage and retain Veterans in smoking cessation counseling (VA Health Services Research and Development Service), 6) Comparing an opt-out to an opt-in approach for smoking cessation in VA primary care clinics (VA Health Services Research and Development Service), and 7) NYU/Abu Dhabi Public Health Research Center.
Principal Investigator, A Female-Specific Cognitive Behavioral Therapy Group for Alcohol Use Disorder in VA Primary Care Settings. Active
Principal Investigator, Behavioral Economic Intervention to Improve Psychiatrist Adherence to Tobacco Treatment Guidelines. Active
Principal Investigator, Comparing an Opt-Out to an Opt-In Approach for Smoking Cessation In VA Primary Care Clinics. Active
Principal Investigator, Financial Incentive Strategies for Smoking Cessation in High-Risk Hospitalized Patients. Active
Principal Investigator, Assessing Use of Alternative Tobacco Products Among Students at City University of New York (CUNY). Completed
Principal Investigator, Center for Alternative Tobacco Product Studies. Completed
Principal Investigator, Effectiveness of Smoking-Cessation Interventions for Urban Hospital Patients. Completed
Principal Investigator, Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants. Completed
Principal Investigator, Midcareer Investigator Award in Patient-Oriented Research. Completed
Principal Investigator, NYU/Abu Dhabi Public Health Research Center. Completed
Principal Investigator, Proactive Outreach for Smokers in VA Mental Health. Completed
Principal Investigator, Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling. Completed


Matulewicz RS, Feuer Z, Birken SA, Makarov DV, Sherman SE, Bjurlin MA, El-Shahawy O (2022).
National assessment of recommendations from healthcare providers for smoking cessation among adults with cancer
Cancer Epidemiology, 78, 102088. doi: 10.1016/j.canep.2021.102088.

Zhao C, Myrie A, Feuer Z, Roberts T, Sherman SE, Bjurlin MA, Matulewicz RS (2022).
Persistent deficiencies in the measurement and reporting of tobacco use in contemporary genitourinary oncology clinical trials
Cancer Epidemiology, 78, 102022. doi: 10.1016/j.canep.2021.102022.

Bjurlin MA, Basak R, Zambrano I, Schatz D, El-Shahawy O, Sherman S, Matulewicz RS (2022).
Perceptions of e-cigarette harm among cancer survivors: Findings from a nationally representative survey
Cancer Epidemiology, 78, 102037. doi: 10.1016/j.canep.2021.102037.

Bjurlin MA, Basak R, Zambrano I, Schatz D, El Shahawy O, Sherman S, Matulewicz RS (2022).
Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis
Cancer Epidemiology, 78, 101913. doi: 10.1016/j.canep.2021.101913.

Jiang N, Xu S, Li L, El-Shahawy O, Freudenberg N, Shearston JA, Sherman SE (2022).
The mediating effect of e-cigarette harm perception in the relationship between e-cigarette advertising exposure and e-cigarette use
International Journal of Environmental Research and Public Health, 19 (10), 6215. doi: 10.3390/ijerph19106215. PMCID: PMC9142075.


Sherman S (2008).
A framework for tobacco control: lessons learnt from Veterans Health Administration
BMJ, 336, 1016-1019. doi: 10.1136/bmj.39510.805266.BE. PMCID: PMC2364861.

Dr. Sherman's MyBibliography Profile